trending Market Intelligence /marketintelligence/en/news-insights/trending/eoWmSYFS0bQq1m1Xu1BmSQ2 content esgSubNav
In This List

Australian Pharmaceutical sells entire shareholding in Sigma

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Australian Pharmaceutical sells entire shareholding in Sigma

Australian Pharmaceutical Industries Ltd. sold 137,264,592 shares of Sigma Healthcare Ltd. — its entire shareholding in the company.

The share sale follows a rejected takeover offer by API to acquire Rowville, Australia-based Sigma in March. The offer consisted of 0.31 of an API share and 23 Australian cents in cash per Sigma share.

Sigma, which is focused on wholesale and distribution of pharmaceutical products, previously said the offer was not in the best interests of its shareholders.

Regarding the decision to off-load its entire Sigma shareholding, API said its board decided that the strategic and commercial "fundamentals" that made the merger a compelling proposition have "significantly diminished."

Camberwell, Australia-based API engages in the wholesale distribution of pharmaceutical, medical, health, beauty and lifestyle products to pharmacies primarily in Australia.